Dodecylphosphocholine
CAS No. 29557-51-5
Dodecylphosphocholine( DPC | DDPPC | n-C12PC | Foscholine-12 | nC12PC | n C12PC )
Catalog No. M24215 CAS No. 29557-51-5
Dodecylphosphocholine is a substrate-type inhibitor of pancreas phospholipase A2. Dodecylphosphocholine is a detergent.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | 27 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDodecylphosphocholine
-
NoteResearch use only, not for human use.
-
Brief DescriptionDodecylphosphocholine is a substrate-type inhibitor of pancreas phospholipase A2. Dodecylphosphocholine is a detergent.
-
DescriptionDodecylphosphocholine is a substrate-type inhibitor of pancreas phospholipase A2. Dodecylphosphocholine is a detergent.
-
In Vitro——
-
In Vivo——
-
SynonymsDPC | DDPPC | n-C12PC | Foscholine-12 | nC12PC | n C12PC
-
PathwayOthers
-
TargetOther Targets
-
Recptorpancreas phospholipase A2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number29557-51-5
-
Formula Weight351.47
-
Molecular FormulaC17H38NO4P
-
Purity>98% (HPLC)
-
SolubilityDMSO:Soluble
-
SMILESCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Goyal S, Qin H, Lim L, Song J. Insoluble protein characterization by circular dichroism (CD) spectroscopy and nuclear magnetic resonance (NMR). Methods Mol Biol. 2015;1258:371-85. doi: 10.1007/978-1-4939-2205-5_21. Review. PubMed PMID: 25447876.
molnova catalog
related products
-
JPH203 dihydrochlori...
JPH203 dihydrochloride is a tyrosine analog, acts as a selective inhibitor of L-type amino acid transporter 1 (LAT1), and is used in cancer research.
-
ZLD1039
ZLD1039 is a potent, orally bioavailable EZH2 (Enhancer of Zeste Homolog 2) inhibitor with high selectivity.
-
Astegolimab
Astegolimab (RG 6149) is a humanised IgG2 monoclonal antibody that targets the IL-33 receptor and inhibits IL-33 signalling. Astegolimab is used in the study of chronic obstructive pulmonary disease (COPD) and severe asthma in adults.
Cart
sales@molnova.com